These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 19822056)

  • 1. The economic burden of disease: comparison between rheumatoid arthritis and ankylosing spondylitis.
    Boonen A; Mau W
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S112-7. PubMed ID: 19822056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-of-illness of rheumatoid arthritis and ankylosing spondylitis.
    Franke LC; Ament AJ; van de Laar MA; Boonen A; Severens JL
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S118-23. PubMed ID: 19822057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of illness in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and systemic lupus erythematosus in Germany.
    Huscher D; Merkesdal S; Thiele K; Zeidler H; Schneider M; Zink A;
    Ann Rheum Dis; 2006 Sep; 65(9):1175-83. PubMed ID: 16540552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.
    Zink A; Braun J; Listing J; Wollenhaupt J
    J Rheumatol; 2000 Mar; 27(3):613-22. PubMed ID: 10743798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility and direct costs: ankylosing spondylitis compared with rheumatoid arthritis.
    Verstappen SM; Jacobs JW; van der Heijde DM; van der Linden S; Verhoef CM; Bijlsma JW; Boonen A
    Ann Rheum Dis; 2007 Jun; 66(6):727-31. PubMed ID: 17172249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year direct and indirect costs for patients with inflammatory rheumatic joint diseases: data from real-life follow-up of patients in the NOR-DMARD registry.
    Kvamme MK; Lie E; Kvien TK; Kristiansen IS
    Rheumatology (Oxford); 2012 Sep; 51(9):1618-27. PubMed ID: 22539479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost of care of rheumatoid arthritis and ankylosing spondylitis patients in tertiary care rheumatology units in Turkey.
    Malhan S; Pay S; Ataman S; Dalkilic E; Dinc A; Erken E; Ertenli I; Ertugrul E; Gogus F; Hamuryudan V; Inanc M; Karaarslan Y; Karadag O; Karakoc Y; Keskin G; Kisacik B; Kiraz S; Oksel F; Oksuz E; Pirildar T; Sari I; Soy M; Senturk T; Taylan A
    Clin Exp Rheumatol; 2012; 30(2):202-7. PubMed ID: 22546069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indirect cost assessment in patients with rheumatoid arthritis (RA): comparison of data from the health economic patient questionnaire HEQ-RA and insurance claims data.
    Merkesdal S; Ruof J; Huelsemann JL; Mittendorf T; Handelmann S; Mau W; Zeidler H
    Arthritis Rheum; 2005 Apr; 53(2):234-40. PubMed ID: 15818718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Societal costs of rheumatoid arthritis in Hong Kong: a prevalence-based cost-of-illness study.
    Zhu TY; Tam LS; Li EK
    Rheumatology (Oxford); 2011 Jul; 50(7):1293-301. PubMed ID: 21330341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G; Andlin-Sobocki P; Brophy S; Jönsson L; Calin A; Braun J
    Rheumatology (Oxford); 2004 Sep; 43(9):1158-66. PubMed ID: 15226514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A multicenter cross-sectional study on the health related quality of life of patients with rheumatoid arthritis using a revised Japanese version of the arthritis impact measurement scales version 2 (AIMS 2), focusing on the medical care costs and their associative factors].
    Hashimoto A; Sato H; Nishibayahi Y; Shiino Y; Kutsuna T; Ishihara Y; Hoshi K; Fujimori J; Tsuboi S; Kondo H; Akizuki M; Moroi Y; Yoshida S
    Ryumachi; 2002 Feb; 42(1):23-39. PubMed ID: 11925904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in patients with rheumatoid arthritis and in patients with ankylosing spondylitis.
    Kiltz U; van der Heijde D
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S108-11. PubMed ID: 19822055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
    Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M;
    J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The economic burden of musculoskeletal disorders on the Italian social security pension system estimated by a Monte Carlo simulation.
    Russo S; Mariani TT; Migliorini R; Marcellusi A; Mennini FS
    Reumatismo; 2015 Sep; 67(2):45-56. PubMed ID: 26492962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective].
    Mould-Quevedo J; Peláez-Ballestas I; Vázquez-Mellado J; Terán-Estrada L; Esquivel-Valerio J; Ventura-Ríos L; Aceves-Avila FJ; Bernard-Medina AG; Goycochea-Robles MV; Hernández-Garduño A; Burgos-Vargas R; Shumski C; Garza-Elizondo M; Ramos-Remus C; Espinoza-Villalpando J; Alvarez-Hernández E; Flores-Alvarado D; Rodríguez-Amado J; Casasola-Vargas J; Skinner-Taylor C;
    Gac Med Mex; 2008; 144(3):225-31. PubMed ID: 18714591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of rheumatoid arthritis on labor force participation, work performance, and healthcare costs in two workplace samples.
    Kessler RC; Maclean JR; Petukhova M; Sarawate CA; Short L; Li TT; Stang PE
    J Occup Environ Med; 2008 Jan; 50(1):88-98. PubMed ID: 18188086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences and similarities between ankylosing spondylitis and rheumatoid arthritis: epidemiology.
    Cross MJ; Smith EU; Zochling J; March LM
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S36-42. PubMed ID: 19822044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ankylosing spondylitis: what is the cost to society, and can it be reduced?
    Boonen A; Severens JL
    Best Pract Res Clin Rheumatol; 2002 Sep; 16(4):691-705. PubMed ID: 12406435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Socioeconomic consequences of ankylosing spondylitis.
    Boonen A
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S23-6. PubMed ID: 12463442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High work disability rate among rheumatoid arthritis patients in Lithuania.
    Dadoniene J; Stropuviene S; Venalis A; Boonen A
    Arthritis Rheum; 2004 Jun; 51(3):433-9. PubMed ID: 15188330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.